Case Presentation: A 45-year-old man with a history of widely metastatic myoepithelial carcinoma and deep venous thrombosis on therapeutic anticoagulation with enoxaparin initially presented with diffuse abdominal and left buttock pain. Of note, a review of prior imaging revealed known metastases in the lungs, peritoneum, bilateral gluteus muscles, and mitral valve chordae/anterior mitral valve leaflet. Computed tomography of the abdomen and pelvis demonstrated increased intraperitoneal and bilateral gluteal metastases as the likely etiology of his increased pain. The patient was started on a fentanyl patient-controlled analgesia pump and planned for therapeutic radiation. One day after admission, he experienced the sudden onset of acute pressure-like substernal chest pain after reaching for a bag. Exam was significant for mild tachycardia and tachypnea, but otherwise he was noted to be hemodynamically stable with normal pulses and cardiovascular exam. His EKG revealed new ST segment elevations in leads II, III and V6, as well as new ST depressions in the anterior leads. Emergent bedside echocardiography demonstrated the persistent mitral valve mobile mass, new akinesis of the lateral wall, and new mild mitral valve regurgitation. Coronary angiography revealed complete occlusion of the mid-left circumflex and first obtuse marginal branch without any other evidence of coronary artery disease; multiple unsuccessful attempts were made to aspirate the thrombus. He required hemodynamic support with an intra-aortic balloon pump for 48 hours after catheterization. The patient was started on tirofiban, aspirin, clopidogrel, metoprolol and atorvastatin. Troponin peaked at 204. Follow-up echocardiography approximately one month later demonstrated an ejection fraction of 40% with akinetic inferoseptal, inferolateral and anterolateral walls and a severely hypokinetic inferior wall, although the patient remained well-compensated without signs or symptoms of heart failure.

Discussion: Hospitalists increasingly care for patients with advanced metastatic disease, and chest pain is a commonly encountered complaint in patients with thoracic or cardiac metastases. Although rare, embolic myocardial infarction (MI) should be on the differential for patients with intracardiac tumors or metastases who present with chest pain. This is the first reported case occurring in a patient with myoepithelial carcinoma. The management of this entity is similar to management of MI of other etiologies, although percutaneous coronary interventions may be less effective secondary to the high risk of distal thrombus migration. These patients may require advanced cardiac support and transfer to facilities capable of providing such care. Embolic MI appears to be associated with significantly increased long-term mortality regardless of the etiology, although further study is needed.

Conclusions: Embolic MI should be suspected in a patient with an intracardiac tumor or metastasis who presents with acute onset chest pain or other symptoms suggestive of cardiac ischemia, regardless of a history of coronary artery disease or cardiac risk factors.